Cargando…
D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed to preven...
Autores principales: | Dartevelle, Pauline, Ehlinger, Claire, Zaet, Abdurraouf, Boehler, Christian, Rabineau, Morgane, Westermann, Benoit, Strub, Jean-Marc, Cianferani, Sarah, Haïkel, Youssef, Metz-Boutigue, Marie-Hélène, Marban, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006364/ https://www.ncbi.nlm.nih.gov/pubmed/29915284 http://dx.doi.org/10.1038/s41598-018-27417-x |
Ejemplares similares
-
D-Cateslytin, a new antimicrobial peptide with therapeutic potential
por: Zaet, Abdurraouf, et al.
Publicado: (2017) -
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
por: Scavello, Francesco, et al.
Publicado: (2021) -
Cateslytin, a Chromogranin A Derived Peptide Is Active against Staphylococcus aureus and Resistant to Degradation by Its Proteases
por: Aslam, Rizwan, et al.
Publicado: (2013) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017) -
Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)